Brain MRI with contrast (FLAIR sequence) Doctors Abroad — Page 3

Dr. Omur Gunaldi is a neurosurgeon at Valued Med Hub Hospitals in Istanbul. He specializes in endoscopic skull base and pituitary surgery. Dr. Gunaldi focuses on brain tumor removal and neuro-oncological cases. He carries the title of associate professor within his specialty.

• Expertise in transnasal tumor resection and complex craniotomy procedures.
• Treats adults and children for brain tumors and pituitary adenomas.
• Established the neurosurgery clinic at Basaksehir Cam and Sakura City Hospital.
• Works at a facility accredited by the Turkish Medical Association.

Dr. Yusuf Acikgoz is a medical oncologist at Lokman Hekim University Ankara Hospital. He specializes in treating complex cancers, including lung, breast, and liver malignancies. He completed a fellowship at Ohio State University in the United States. Dr. Acikgoz manages treatments like chemotherapy, radioembolization, and immunotherapy.

• Member of the American Society of Clinical Oncology (ASCO).
• Assistant Investigator for Phase III clinical trials, including the CheckMate-649 study.
• Certified in Good Clinical Practice and Human Subjects Protection at Ohio State University.
• Performs diagnostic procedures like biopsy, gastroscopy, and tumor marker testing.

Dr. Ramazan Uyar is a neurosurgeon at Medical Park Antalya Hospital Complex. He specializes in aneurysm surgery and cerebrospinal tumor removal. Dr. Uyar won the Dr. Cengiz Çetin thesis prize from the Istanbul Chamber of Medicine. He treats a wide range of pediatric and adult neurological conditions.

• Performs complex spine surgeries for lumbar and neck hernias.
• Treats pediatric neurosurgery cases including hydrocephalus and craniostenosis.
• Handles surgical repair of brain aneurysms and arteriovenous malformations.
• Works at the largest private hospital in the Mediterranean region.

Dr. Serdal Gungor is a pediatric neurosurgeon at Medical Park Antalya Hospital Complex. He focuses on treating complex brain and spine conditions in children. Dr. Gungor completed his subspecialty training at the prestigious Hacettepe University. He performs intricate procedures like brain tumor removal, epilepsy surgery, and shunt placements.

• Treats congenital conditions including spina bifida and Arnold Chiari syndrome.
• Uses precise technologies like Gamma Knife and CyberKnife for pediatric brain tumors.
• Member of the International Child Neurology Association (ICNA).
• Works at the Mediterranean region’s largest private medical facility.

Dr. Ibrahim Bayar Cinar is a cardiovascular surgeon at Medical Park Bahcelievler Hospital in Istanbul. He specializes in treating mitral valve prolapse and aortic valve insufficiency. Dr. Cinar completed a clinical fellowship at the University of Ottawa Heart Center in Canada. He holds memberships in the European Society for Cardiovascular Surgery and Vascular Surgery.

• Served as a Professor of Cardiovascular Surgery at Altınbaş University.
• Treats complex conditions like aorto-mesenteric artery compression syndrome.
• Performs cardiac procedures at a JCI-accredited university hospital.
• Practices at a national reference center for cardiovascular surgery and intensive care.

Dr. Erkan Kaptanoglu is a neurosurgeon at Estexper Clinic in Istanbul. He specializes in complex spine surgery, pediatric neurosurgery, and brain tumor resection. Dr. Kaptanoglu won first place in the Acibadem Hospital Medical Research Awards. He completed a research fellowship in spinal cord regeneration at the University of Toronto.

• Expertise includes surgeries for scoliosis, kyphosis, and sacral tumors.
• Treats complex conditions like pituitary adenomas, hydrocephalus, and brain aneurysms.
• Former Chairman of the Spinal and Peripheral Nerve Surgery Group in Turkey.
• Published over 100 scientific articles and edited 7 medical books.

Dr. Tuncay Kaner is a spine neurosurgeon at Medical Park Bahcelievler Hospital. He completed a fellowship at the UCLA Santa Monica Comprehensive Spine Center. Dr. Kaner is an active member of the Scoliosis Research Society. He also holds a membership in AO Spine International. He serves at a JCI-accredited university hospital in Istanbul.

• Specializes in endoscopic discectomy and minimally invasive fusion surgery.
• Served as a visiting faculty member at the University of Virginia.
• Treats complex spinal stenosis, brain tumors, and herniated disks.
• Is a member of the Society for Minimal Intervention in Spinal Surgery.

Dr. Evren Sandal is a neurosurgeon at Medicalpoint International Hospital in İzmir. He specializes in skull base, neurovascular, and craniocervical junction surgery. Dr. Sandal completed focused research in cerebral bypass surgery at the University of Wisconsin, USA. He treats complex conditions including brain tumors, spinal stenosis, and brain cysts.

• Trained in skull base surgery at a leading US university medical center.
• Performs specialized procedures like discectomy and deep brain stimulation (DBS).
• Collaborated with global experts in craniocervical junction and cerebral bypass techniques.
• Works at JCI-accredited Medicalpoint Hospital, which features a dedicated Robotic Surgery Center.

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Ali Osman Mucuoglu is a neurosurgeon at Atlas University Hospital in Istanbul. He specializes in brain tumor removal and minimally invasive intracerebral hemorrhage surgery. Dr. Mucuoglu utilized 3D printing technology for assisted transsphenoidal hypophysectomy. He is a member of the European Association of Neurosurgical Societies.

• Completed neurosurgery training at Dokuz Eylül University.
• Treats complex conditions including spinal stenosis, spondylolisthesis, and acoustic neuroma.
• Performs deep brain stimulation (DBS) and vagus nerve stimulation surgery.
• Specialized in surgical neuroanatomy and head injury management.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Lee Sanggu, MD, PhD, is a neurosurgeon. He is the Honorary Medical Director and Director of the Spine Center. He is also a Professor of Neurosurgery at Gachon University Gil Medical Center.

Clinical focus includes spine tumors, spinal disorders, minimally invasive spine surgery, and cervical disorders. Procedures include PEN, PNP, selective nerve block, microscopic or endoscopic discectomy, artificial disc replacement, minimally invasive spinal fusion, and vertebroplasty.

He earned a PhD in Medicine from Hanyang University. He served as Chief of Neurosurgery at the Veterans Health Service Medical Center. He is an executive board member of KNS, KNTS, and KSNS. He has served as Vice President and President of KSCS. He is a past president of KOMISS, KAME, and KSPNS. He is an AOSpine Asia Pacific Committee member and a full member of NASS. He was listed in Marquis Who’s Who in 2010.

Dr. Mehmet Hakan Şahin is a neurosurgeon at Atlas University Hospital (as of 2026). He specializes in neuro-oncological and neurovascular surgery. He also performs skull base, complex cranial, and spine surgery. He was an Assistant Professor at Atatürk University (2019–2024). He served at UW Health (2024–2025).

He has 29 international peer-reviewed papers and 11 national papers. He has written 5 textbook chapters. He has given 7 oral presentations, including at AANS 2025 and a 2024 panel on supratotal glioma resection. His honors include the 2024 Turkish Neurosurgery Association Young Neurosurgeon Incentive Award (Second Prize) and 1st Prize at the 1st Yaşargil Microneurosurgery Academy. He holds the Turkish Neurosurgery Qualification Certificate (2023). He has been a member of the Turkish Neurosurgery Association since 2017 (No. 1620).

Dr. Han Yeongmin is a neurosurgeon (MD, PhD). He is Medical Director and Director of the Neurosurgery Center at Incheon St. Mary’s Hospital. He treats cerebrovascular disease and peripheral nerve disorders. He also specializes in brain tumors and skull base surgery. Conditions include stroke, cerebral hemorrhage, cerebral infarction, and moyamoya disease. He performs PEN, PNP, and SNB. He also offers microscopic and endoscopic discectomy, artificial disc replacement, MIS-TLIF/minimally invasive spinal fusion, and vertebroplasty.

He earned his MD and PhD from The Catholic University of Korea. He served as a visiting professor in cerebrovascular and skull base surgery at Barrow Neurological Institute (Phoenix, Arizona, USA). He also served at Harborview Medical Center, University of Washington (Seattle, USA).

His publications include co-authorship of Chapter 52 of the Textbook of Korean Cerebrovascular Surgery. He also co-authored Acoustic Neuroma Oncology. He is a full member of KNS, KSCVS, KSBS, KBTS, KNTS, KSNS, and KSPNS.

Dr. Halil Can is a Professor of Neurosurgery at İstinye University Liv Hospital Topkapı. He specializes in endoscopic and microsurgical spine surgery for tumors and degenerative diseases. Dr. Can is an author of 21 international peer-reviewed publications. He performs complex procedures including endoscopic skull base and pituitary surgery.

• Conducted Phase I safety trials for stem-cell treatments in spinal cord injuries.
• Reported on surgical outcomes for 81 posterior circulation aneurysm cases.
• Expert in advanced pain management like intradiscal ozone therapy and laser nucleoplasty.
• Performs functional neurosurgery including Parkinson's surgery and spinal cord stimulator implantation.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Ali Ihsan Anadolulu is a surgical specialist at Central Hospital in Istanbul. He focuses on pediatric gastrointestinal surgery and anorectal malformations. Dr. Anadolulu treats complex colorectal and pelvic floor disorders in children. He uses minimally invasive techniques for pediatric surgical cases.

• Performs specialized surgeries for nephroblastoma and rhabdomyosarcoma removal.
• Treats motility disorders and anorectal malformations in pediatric patients.
• Expert in pituitary tumor surgery for children and adolescents.
• Works at Central Hospital, which features modern neonatal intensive care units.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.